Go back to homepage
| Pfizer Animal Health | |
| Financial Details | |
| Total Company Revenue in 2010 | $ 67 Bn |
| Revenue from Animal Health Market in 2010 | $ 3.575 Bn |
| % of revenue from Animal Health in 2010 | 5.34% |
| Segmentwise Revenue Breakup ($ Bn) | |
| Livestock Vaccines | 2.145 |
| Companion Vaccines | 1.43 |
| Number of Major Vaccines (Animal-wise) | |
| Poultry | 2 |
| Swine | 4 |
| Fish | 2 |
| Sheep | 4 |
| Cattle | 2 |
| Canine | 16 |
| Feline | 9 |
| Equine | 1 |
| Mergers and Acquisitions (2009 - 2011) | Consideration |
| Wyeth | $ 68 Bn |
| Synbiotics Corp | $ 735 Mn |
| RFCL-Vetnex Animal Health Unit | $ 75 Mn |
| Microtek International Inc | undisclosed |
| King Pharmaceuticals Inc | $ 3.6 Bn |
| Future Focus Areas | |
| Veterinary Vaccines under trial | 0 (Innovative Vaccines in the last few years: 2 vaccines for dogs, 2 vaccines for swine, 1 for cattle) |
| Future Focus Areas of the company in the Veterinary Vaccines Market | Vaccines for emerging diseases such as blue-tongue, African horse sickness |
| Vaccines for dogs and cats | |
Go back to homepage